Commodore Capital LP - 09 Mar 2026 SCHEDULE 13G Report for AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

Filing Manager
Commodore Capital LP
Reporting Manager
Commodore Capital LP
Security
AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
ANTX
Shares outstanding
37,347,828 shares
Disclosed Ownership
3,697,435 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
16 Mar 2026, 16:21:14 UTC
Date of event
09 Mar 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Commodore Capital LP 9.9% 3,697,435 0 3,697,435 Michael Kramarz Managing Partner
Commodore Capital Master LP 9.9% 3,697,435 0 3,697,435 Michael Kramarz Authorized Signatory
Robert Egen Atkinson 9.9% 3,697,435 0 3,697,435 Robert Egen Atkinson Authorized Signatory
Michael Kramarz 9.9% 3,697,435 0 3,697,435 Michael Kramarz Authorized Signatory